VENUS REMEDIES LTD. - 526953 - Shareholding for the Period Ended December 31, 2020
Venus Remedies Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2020. For more details, kindly Click here15-01-2021
VENUS REMEDIES LTD. - 526953 - Shareholding for the Period Ended December 31, 2020
Venus Remedies Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2020. For more details, kindly Click hereVENUS REMEDIES LTD. - 526953 - Statement Of Investor Complaints For The Quarter Ended December 2020
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0660 Name of the Signatory :- NehaDesignation :- Company Secretary and Compliance OfficerVENUS REMEDIES LTD. - 526953 - Disclosure Of Related Party Transaction Pursuant To Regulation 23(9) Of The SEBI ( Listing Obligations & Disclosures Requirements) Regulations, 2015
Disclosure of Related Party Transaction pursuant to Regulation 23(9) of the SEBI ( Listing Obligations & Disclosures Requirements) Regulations, 2015VENUS REMEDIES LTD. - 526953 - Board Meeting Intimation for Finalization Of Date, Time Of Extra Ordinary General Meeting (EGM) Of The Company And Others As Per Attachment
VENUS REMEDIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 15/01/2021 ,inter alia, to consider and approve 1. Finalization of date, time of Extra Ordinary General Meeting (EGM) of the Company. 2. To consider and approve draft Notice of EGM 3 .To consider and approve revision in remuneration of wholetime directors 4. Any other business with the permission of Chair.VENUS REMEDIES LTD. - 526953 - Clarification On Price Movement
This has reference to your letter ref no. L/SURV/ONL/PV/RS/ 2020-2021 / 2932 dated 06.01.2021 with regard to significant movement in price of Venus Remedies Limited. In this regard we wish to inform you that Company has made all the necessary disclosures in accordance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 from time to time and has not withheld any material information that in our opinion would have a bearing on the price / volume behavior in the company''s script. The said significant movement in the share price is purely market driven.VENUS REMEDIES LTD. - 526953 - Clarification sought from Venus Remedies Ltd
The Exchange has sought clarification from Venus Remedies Ltd on January 6, 2021 with reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.The reply is awaited.VENUS REMEDIES LTD. - 526953 - Closure of Trading Window
Closure of trading window for designated employeesVENUS REMEDIES LTD. - 526953 - Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Venus Remedies Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click hereVENUS REMEDIES LTD. - 526953 - Disclosure Of Voting Results Of 31St Annual General Meeting Of The Company Under Regulation 44(3) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Disclosure of Voting Results of 31st Annual General Meeting of the Company under Regulation 44(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015